Latest Financial Guidance News

Mesoblast Limited reports a robust 66% increase in Ryoncil revenues for Q2 2025, driven by strong market adoption and new Medicare reimbursement codes.

Opthea Limited has received a substantial A$10.8 million R&D tax incentive from the Australian government, reinforcing its commitment to advancing its novel drug candidate sozinibercept. This funding milestone underscores the company’s strategic focus on innovation and fiscal discipline.

Electro Optic Systems has landed a significant A$108 million contract to supply remote weapon systems for the Australian Defence Force’s LAND 400-3 project, integrating its technology with Hanwha’s Redback Infantry Fighting Vehicles.

BlackRock Investment Management (Australia) Limited has announced confirmed cash distributions for a suite of Australian domiciled iShares ETFs, detailing payment schedules and reinvestment options for investors.

DigiCo Infrastructure REIT has secured new customers boosting Australian contracted IT capacity to 41MW by mid-2026, prompting an upward revision of its FY26 earnings guidance and accelerated development plans at its flagship SYD1 data centre.

Dexus Industria REIT has acquired two fully leased industrial warehouses in Melbourne’s Dandenong South for $47.5 million, reinforcing its strategic focus on industrial assets and maintaining its FY26 financial guidance.

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, citing a strong British pound and increased project activity in EMEA as key growth drivers.

Spirit Technology Solutions forecasts strong FY26 growth with revenue surpassing $114 million and underlying EBITDA rising between 14% and 23%. The company signals ongoing expansion through organic and potential inorganic avenues.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.

ReNerve Ltd has launched its Empliq product range, marking its entry into the dermal and amniotic tissue repair markets with first sales already recorded and a US launch planned.

Regis Healthcare reveals a funding update amid government changes, projecting modest EBITDA growth despite a funding gap and rising wage costs.